DBVT insider transaction filings
DBV Technologies S.A. — 12 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-31. Screen DBVT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-31 | 4 | Mohideen Pharis — Chief Medical Officer | Sale (S): 464 @ $2.70 | EDGAR |
| 2026-02-02 | 4 | Mohideen Pharis — Chief Medical Officer | Sale (S): 534 @ $4.86 | EDGAR |
| 2026-01-14 | 4 | BAKER BROS. ADVISORS LP — Director Baker Bros. Advisors (GP) LLC — Director 667, L.P. — Director Baker Brothers Life Sciences LP — Director BAKER FELIX — Director BAKER JULIAN — Director | Option exercise (M): 2,299,656 (derivative) @ $0 · Option exercise (M): 25,005,240 (derivative) @ $0 · Option exercise (M): 2,299,656 (derivative) @ $0 · Option exercise (M): 25,005,240 (derivative) @ $0 | EDGAR |
| 2025-12-19 | 4 | EPIC Bpifrance Bpifrance Participations SA Bpifrance SA Bpifrance Investissement S.A.S. CAISSE DES DEPOTS ET CONSIGNATIONS | Sale (S): 2,036,990 @ $4.84 · Sale (S): 40,000 @ $5.28 · Sale (S): 1,292,103 @ $4.19 | EDGAR |
| 2025-11-25 | 4 | Mohideen Pharis — Chief Medical Officer | Sale (S): 6,496 @ $2.88 · Sale (S): 1,624 @ $2.77 · Grant/award (A): 44,000 @ $0 · Grant/award (A): 253,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Trapp Kevin Michael — Chief Commercial Officer | Grant/award (A): 55,000 @ $0 · Grant/award (A): 316,250 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Boucinha Virginie — Chief Financial Officer | Grant/award (A): 32,000 @ $0 · Grant/award (A): 192,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Tasse Daniel — CHIEF EXECUTIVE OFFICER, Director | Grant/award (A): 964,000 (derivative) @ $0 | EDGAR |
| 2025-07-31 | 4 | Mohideen Pharis — Chief Medical Officer | Sale (S): 464 @ $2.22 | EDGAR |
| 2025-05-27 | 4 | Mohideen Pharis — Chief Medical Officer | Sale (S): 397 @ $1.84 | EDGAR |
| 2025-03-31 | 4 | BAKER BROS. ADVISORS LP — Director, 10% owner Baker Bros. Advisors (GP) LLC — Director, 10% owner 667, L.P. — Director, 10% owner Baker Brothers Life Sciences LP — Director, 10% owner BAKER FELIX — Director, 10% owner BAKER JULIAN — Director, 10% owner | Grant/award (A): 2,299,656 (derivative) · Grant/award (A): 25,005,240 (derivative) · Grant/award (A): 2,299,656 (derivative) · Grant/award (A): 25,005,240 (derivative) | EDGAR |
| 2025-01-31 | 4 | Mohideen Pharis — Chief Medical Officer | Sale (S): 600 @ $0.85 | EDGAR |
Recent 8-K events — DBV Technologies S.A.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-03 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-05 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-20 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-16 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=DBVT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →